XML 21 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Non-Controlling Interests
Balance, beginning of period at Dec. 31, 2019 $ 2,761.5 $ 1.2 $ 3,370.6 $ 3,494.1 $ (441.0) $ (3,681.9) $ 18.5
Balance, beginning of period (in shares) at Dec. 31, 2019   117,190,883          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 1.7     1.7      
Other comprehensive loss (64.8)       (64.8)    
Issuances under equity plans (0.5)   5.9     (6.4)  
Issuances under equity plans (in shares)   293,298          
Share-based compensation expense 4.6   4.6        
Repurchases of common stock (63.8)         (63.8)  
Noncontrolling interest transactions 0.3           0.3
Balance, end of period at Mar. 31, 2020 2,639.0 $ 1.2 3,381.1 3,495.8 (505.8) (3,752.1) 18.8
Balance, end of period (in shares) at Mar. 31, 2020   117,484,181          
Balance, beginning of period at Dec. 31, 2020 2,453.6 $ 1.2 3,402.5 3,388.8 (397.3) (3,954.2) 12.6
Balance, beginning of period (in shares) at Dec. 31, 2020   117,555,991          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 62.0     62.0      
Other comprehensive loss (40.5)       (40.5)    
Issuances under equity plans (3.6)   1.0     (4.6)  
Issuances under equity plans (in shares)   169,192          
Share-based compensation expense 7.5   7.5        
Repurchases of common stock (100.1)         (100.1)  
Noncontrolling interest transactions (1.5)           (1.5)
Balance, end of period at Mar. 31, 2021 $ 2,377.4 $ 1.2 $ 3,411.0 $ 3,450.8 $ (437.8) $ (4,058.9) $ 11.1
Balance, end of period (in shares) at Mar. 31, 2021   117,725,183